MedTrace Logo

Primary Prevention With the Lifestyle Tool

NCT05309850 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90000

Last updated 2025-07-16

No results posted yet for this study

Summary

In this study participants will be randomized to use a digital lifestyle tool over three years or to a control group without access to the tool. The investigators will prospectively via clinical registries follow the incidence and development of type 2 diabetes and cardiovascular disease in those using the tool regularly and those in the control group.

Conditions

Interventions

BEHAVIORAL

Lifestyle tool

Regular use of the digital Lifestyle tool

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Anders Rosengren · Göteborg University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-05
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309850 on ClinicalTrials.gov